American Diabetes Association
Save Obesity Medication Coverage in Indiana
As you may know, states across the nation are taking action to allow coverage of obesity medications, such as GLP-1s, to combat obesity and prevent more costly conditions like type 2 diabetes and heart and kidney diseases.

Unfortunately, the State of Indiana recently notified their state employees they will lose coverage of their GLP-1 medications for obesity treatment as of January 1, 2026.

TAKE ACTION! Send a quick note to Governor Braun and your state legislators to urge them to make obesity treatment and prevention a priority! 

Have you had success managing your obesity with a GLP-1 medication? If so, please consider personalizing your message to reflect your own experiences. Your story will make your message more memorable and likely to influence policymakers’ decisions.

    Subject
    Message Body
    Remaining: 0
    Post
    Remaining: 0
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      By providing your mobile number, you agree to receive periodic call to action text messages from American Diabetes Association. Message and data rates may apply. Reply HELP for help. Reply STOP to unsubscribe. Message frequency varies. Privacy Policy  
      Home Information

      Enter Your Info